Emerging research highlights a strong link between gut microbiota and the pathophysiology of polycystic ovary syndrome (PCOS). Dysbiosis in the gut may contribute to metabolic, hormonal, and inflammatory imbalances commonly seen in PCOS patients. Understanding this connection opens new avenues for targeted therapies, including dietary strategies, probiotics, and microbiota-based interventions.
AUTHOR: Sara Kralj, MSc, Master in Nutrition
Welcome to B2B Nutramedic&Cosmetics web platform, your premier web platform and digital magazine for professionals in the food supplements and cosmetics industry.
Our mission is to provide the latest industry news, research, and insights to help you stay ahead in your field.
Terms of use | Privacy policy
DARMELL d.o.o. za usluge
Cvjetna cesta 11
10 000 Zagreb, Hrvatska
Telefon: +385 (91) 681 24 44
MB: 05638950
OIB: 81797383386
IBAN HR7124020061101112680
ERSTE&STEIERMARKISHE BANK d.d.,
Temeljni kapital u iznosu 20.000,00 kn plaćen u cijelosti
Direktor: Daria Šurić
Contact | About us | Advertise
Terms of use | Privacy policy
DARMELL d.o.o. za usluge | Cvjetna cesta 11, 10 000 Zagreb, Hrvatska | Telefon: +385 (91) 681 24 44 | MB: 05638950 | OIB: 81797383386 | IBAN HR7124020061101112680 ERSTE&STEIERMARKISHE BANK d.d. | Temeljni kapital u iznosu 20.000,00 kn plaćen u cijelosti | Direktor: Daria Šurić
© 2023 B2B NUTRAMEDIC & COSMETICS
Designed&Developed by: BoomBushBoo